Interval Debulking Surgery | List of Frontiers open access articles

Original Research

Published on 26 Mar 2021

Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer

in Women's Cancer

Minjun He
Yuerong Lai
Hongyu Peng
Chongjie Tong

Frontiers in Oncology

doi 10.3389/fonc.2021.646135

4,045 views
12 citations

Original Research

Published on 12 Sep 2022

No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study

in Surgical Oncology

Mengmeng Lyu
Jin Lu
Yang Shen
Qianqian Chen
Fei Deng
Jinhua Wang

Frontiers in Surgery

doi 10.3389/fsurg.2022.997344

2,577 views

Original Research

Published on 28 Jul 2022

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study

in Gynecological Oncology

Yong Jae Lee
Ki Eun Seon
Dae Chul Jung
Jung-Yun Lee
Eun Ji Nam
Sang Wun Kim
Sunghoon Kim
Young Tae Kim

Frontiers in Oncology

doi 10.3389/fonc.2022.936099

3,538 views
7 citations

Systematic Review

Published on 18 Jul 2022

Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis

in Gynecological Oncology

Siyuan Zeng
Yongai Yu
Yuemei Cui
Bing Liu
Xianyu Jin
Zhengyan Li
Lifeng Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.900256

4,894 views
14 citations

Original Research

Published on 09 Sep 2025

Neoadjuvant hyperthermic intraperitoneal chemotherapy: impact on chemotherapy response score and prognosis in high-grade serous ovarian carcinoma

in Gynecological Oncology

Xiaojie Feng
Yuhua Wang
Han Li
Ye Zhang
Lei Li
Yanying Ma
Shanping Wang
Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1639810

1,640 views

Systematic Review

Published on 30 May 2025

Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Yijun Wang
Yicong Wang
Lei Wang
He Yuan
Yongai Yu
Daju Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566604

3,999 views

Original Research

Published on 12 Jan 2026

Predictive value of the KELIM in neoadjuvant treatment for patients with advanced ovarian cancer

in Gynecological Oncology

Yicong Wang
Yongai Yu
He Yuan
Lei Wang
Pengfei Bian
Yiming Yang
Jiao Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1677070

1,206 views

Original Research

Published on 24 Apr 2026

Impact of the COVID-19 pandemic on ovarian cancer diagnosis, treatment, and survival in a Swiss tertiary care hospital - a conclusion five years after the outbreak of the pandemic

in Surgical Oncology

Andrea Gmür
Denis Favre
Damaris Erhardt
Hannes Egli
Julian Wampfler
Flurina Saner
Sara Imboden
Michael D. Mueller
Franziska Siegenthaler

Frontiers in Oncology

doi 10.3389/fonc.2026.1664719

417 views

Original Research

Published on 10 Feb 2023

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy

in Cancer Immunity and Immunotherapy

Beatris Mastelic-Gavillet
Apostolos Sarivalasis
Leyder Elena Lozano
Sebastien Lofek
Tania Wyss
Ignacio Melero
I. Jolanda M. de Vries
Alexandre Harari
Pedro Romero
Lana Elias Kandalaft

Frontiers in Immunology

doi 10.3389/fimmu.2023.1119371

6,235 views
6 citations

Original Research

Published on 07 Apr 2026

Prognostic value of the CT-based Suidan scoring system in advanced epithelial ovarian cancer

in Cancer Imaging and Image-directed Interventions

Chao Deng
Dan Yan
Hai-Bo Qu
Yan Zeng
Li-Hua Deng
Feng-Lin Jia
Xi-Jian Chen
Gang Ning

Frontiers in Oncology

doi 10.3389/fonc.2026.1777388

421 views

Brief Research Report

Published on 09 Mar 2026

Integrating chronic inflammation and hypoxia: the potential role of HIF-1α in tumor behavior and therapy response in high-grade serous ovarian cancer

in Inflammation

Sara Polajžer
David Lukanović
Erik Škof
Borut Kobal
Katarina Černe

Frontiers in Immunology

doi 10.3389/fimmu.2026.1757708

503 views

Original Research

Published on 28 May 2024

Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study

in Gynecological Oncology

Jing Huang
Danyi Du
Hailong Chen
Deping Luo
Qi Wang
Chan Li
Yuanxiang Li
Ying Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399502

2,568 views
6 citations

Original Research

Published on 10 Aug 2023

Impact of supradiaphragmatic lymphadenectomy on the survival of patients in stage IVB ovarian cancer with thoracic lymph node metastasis

in Gynecological Oncology

Soo Jin Park
Kwon Joong Na
Maria Lee
In Kyu Park
Hyun Hoon Chung
Chang Hyun Kang
Jae-Weon Kim
Noh Hyun Park
Young-Tae Kim
Yong Sang Song

Frontiers in Oncology

doi 10.3389/fonc.2023.1203127

3,253 views
3 citations

Original Research

Published on 31 Mar 2026

Chemotherapy driven alterations in NK cell receptors and ligands in high grade serous ovarian cancer

in Cancer Immunity and Immunotherapy

Pavan Kumar
Samruddhi Ranmale
Sanket Mehta
Hemant Tongaonkar
Vashishth Maniar
Jayanti Mania-Pramanik

Frontiers in Immunology

doi 10.3389/fimmu.2026.1765987

512 views

Original Research

Published on 28 Jun 2022

Use of Laparoscopic and Laparotomic J-Plasma Handpiece in Gynecological Malignancies: Results From A Pilot Study in A Tertiary Care Center

in Gynecological Oncology

Salvatore Gueli Alletti
Andrea Rosati
Vito Andrea Capozzi
Matteo Pavone
Alessandro Gioè
Stefano Cianci
Vito Chiantera
Giuseppe Vizzielli
Giulia Scaglione
Anna Fagotti

Frontiers in Oncology

doi 10.3389/fonc.2022.868930

2,947 views
5 citations

Original Research

Published on 02 Feb 2024

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China

in Gynecological Oncology

Jinghong Chen
Mengpei Zhang
Kemin Li
Yuanqiong Duan
Jing Zeng
Qingli Li
Danqing Wang
Liang Song
Qintong Li
Rutie Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1336616

5,431 views
7 citations

Articles

Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer

No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study

Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis

Neoadjuvant hyperthermic intraperitoneal chemotherapy: impact on chemotherapy response score and prognosis in high-grade serous ovarian carcinoma

Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis

Predictive value of the KELIM in neoadjuvant treatment for patients with advanced ovarian cancer

Impact of the COVID-19 pandemic on ovarian cancer diagnosis, treatment, and survival in a Swiss tertiary care hospital - a conclusion five years after the outbreak of the pandemic

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy

Prognostic value of the CT-based Suidan scoring system in advanced epithelial ovarian cancer

Integrating chronic inflammation and hypoxia: the potential role of HIF-1α in tumor behavior and therapy response in high-grade serous ovarian cancer

Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study

Impact of supradiaphragmatic lymphadenectomy on the survival of patients in stage IVB ovarian cancer with thoracic lymph node metastasis

Chemotherapy driven alterations in NK cell receptors and ligands in high grade serous ovarian cancer

Use of Laparoscopic and Laparotomic J-Plasma Handpiece in Gynecological Malignancies: Results From A Pilot Study in A Tertiary Care Center

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China